[SLRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -48.48%
YoY- -229.10%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 -1,840 0 571 -
PBT -6,371 -14,409 -4,718 -6,109 -4,105 -3,737 -3,074 62.34%
Tax 111 -78 -38 -14 -44 -10 -42 -
NP -6,482 -14,331 -4,718 -6,095 -4,105 -3,737 -3,074 64.21%
Tax Rate - - - - - - - -
Total Cost 6,482 14,331 4,718 6,095 2,265 3,737 3,646 46.60%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 223.06 0.00 -538.05 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -2.88 -6.38 -2.20 -3.29 -2.27 -2.09 -1.72 40.87%
EPS Diluted -2.88 -6.38 -2.20 -3.29 -2.27 -2.09 -1.72 40.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.